How did Baxter's revenue and expenses shift in Q4 2024?

Baxter International's financial metrics for Q4 2024 show a slight increase in total revenue, while costs remained relatively stable with a minor decrease in cost of sales and a slight increase in R&D and selling, general, and administrative expenses:

1. **Revenue Growth**: The total revenue for Baxter International in Q4 2024 was $2.75 billion, representing a year-over-year growth of 0.01%.
2. **Cost of Sales**: The cost of sales decreased by 1.07%, from $1.79 billion to $1.63 billion.
3. **R&D Expenses**: Research and development (R&D) expenses increased by 0.66%, from $127 million to $211 million.
4. **Selling, General, and Administrative Expenses**: These expenses also saw a slight increase of 0.11%, amounting to $761 million.
5. **Profitability Implications**: The slight increase in revenue and R&D expenses, while costs of sales decreased, suggests a more efficient cost structure. However, the overall increase in expenses and the slight revenue growth indicate that Baxter is focusing on innovation and maintaining its market position.

|code|Ticker|Name|Date|Selling, General, and Administrative Expenses|Cost of Goods Sold|R&D Expenses|Total Revenue|Advertising and Marketing Expenses|market_code|
|---|---|---|---|---|---|---|---|---|---|
|BAX|BAX.N|Baxter International|2024 Q1|1.027E9|2.205E9|1.76E8|3.592E9||169|
|BAX|BAX.N|Baxter International|2024 Q2|1.021E9|2.381E9|1.73E8|3.812E9||169|
|BAX|BAX.N|Baxter International|2024 Q3|7.54E8|1.666E9|1.29E8|2.699E9||169|
|BAX|BAX.N|Baxter International|2024 Q4|7.61E8|1.794E9|2.11E8|2.753E9||169|